MESTINON

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug MESTINON contains one active pharmaceutical ingredient (API):

1	Pyridostigmine UNII KVI301NA53 - PYRIDOSTIGMINE BROMIDE
	Pyridostigmine is an antagonist to cholinesterase, the enzyme which normally destroys acetylcholine. The action of pyridostigmine can briefly be described, therefore, as the potentiation of naturally occurring acetylcholine.
	Read more about Pyridostigmine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MESTINON Tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N07AA02	Pyridostigmine	N Nervous system → N07 Other nervous system drugs → N07A Parasympathomimetics → N07AA Anticholinesterases
Discover more medicines within N07AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1959D, 2608G, 2724J
BR	Câmara de Regulação do Mercado de Medicamentos	541718030017817
CA	Health Products and Food Branch	00869953, 00869961
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	4865-MEE-1119, 4870-MEE-1119
EE	Ravimiamet	1480564, 1664625, 1664647
ES	Centro de información online de medicamentos de la AEMPS	23524
FI	Lääkealan turvallisuus- ja kehittämiskeskus	173898, 173948
FR	Base de données publique des médicaments	67013510, 68333755
GB	Medicines & Healthcare Products Regulatory Agency	185923, 199693, 24834, 373649
HK	Department of Health Drug Office	03376, 03386, 58081
HR	Agencija za lijekove i medicinske proizvode	HR-H-198605655
IE	Health Products Regulatory Authority	33855, 36700
IL	מִשְׂרַד הַבְּרִיאוּת	334
JP	医薬品医療機器総合機構	1239003F1046
LT	Valstybinė vaistų kontrolės tarnyba	1004557
MT	Medicines Authority	MA1507/01401, PI565/78601A, PI729/27301A
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	44564, 530M2002
NL	Z-Index G-Standaard, PRK	6203, 6211
NZ	Medicines and Medical Devices Safety Authority	10009
PL	Rejestru Produktów Leczniczych	100116797, 100442189
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68713001, W68713002, W68713003
SG	Health Sciences Authority	02898P, 03214P
TR	İlaç ve Tıbbi Cihaz Kurumu	8698856120021
US	FDA, National Drug Code	0187-3010, 0187-3012, 0187-3013
ZA	Health Products Regulatory Authority	C/5.3/610, UX/5.3/179